David P Kosow

Title: David P Kosow: Innovator in Hemophilia Treatment

Introduction

David P Kosow is a notable inventor based in Monrovia, CA (US). He has made significant contributions to the field of hemophilia treatment through his innovative patents. With a total of 2 patents, Kosow has focused on enhancing the processes involved in the separation and purification of critical blood factors.

Latest Patents

Kosow's latest patents include a process for preparing fibronectin and antihemophilic factor (Factor VIII) concentrates from blood plasma cryoprecipitate. This innovative method aims to improve the efficiency of obtaining these vital components. Another significant patent involves the purification of Factor VIII complex using heparin affinity chromatography. This process allows for the effective separation of Factor VIII complex from an impure protein fraction, utilizing a heparin-coupled chromatographic medium to bind the complex, which is then recovered through elution with an aqueous CaCl₂ solution.

Career Highlights

David P Kosow has worked with Alpha Therapeutic Corporation, where he has applied his expertise in biochemistry and protein purification. His work has been instrumental in advancing treatments for hemophilia, a condition that affects many individuals worldwide.

Collaborations

Throughout his career, Kosow has collaborated with esteemed colleagues such as Prabir Bhattacharya and Charles F Sternburg. These partnerships have contributed to the development of innovative solutions in the field of hemophilia treatment.

Conclusion

David P Kosow's contributions to the field of hemophilia treatment through his patents and collaborations highlight his dedication to improving patient care. His innovative approaches continue to influence the medical community and enhance the quality of life for those affected by hemophilia.